Open Access
Research Article
Issue
Parasite
Volume 29, 2022
Article Number 7
Number of page(s) 13
DOI https://doi.org/10.1051/parasite/2022008
Published online 10 February 2022
  1. Abedini A, Chollet S, Angelis A, Borie N, Nuzillard J-M, Skaltsounis A-L, Reynaud R, Gangloff SC, Renault J-H, Hubert J. 2016. Bioactivity-guided identification of antimicrobial metabolites in Alnus glutinosa bark and optimization of oregonin purification by centrifugal partition chromatography. Journal of Chromatography B, 1029–1030, 121–127. [CrossRef] [Google Scholar]
  2. Barthel A, Stark S, Csuk R. 2008. Oxidative transformations of betulinol. Tetrahedron, 64, 9225–9229. [CrossRef] [Google Scholar]
  3. del Carmen Recio M, Giner R, Máñez S, Ríos J. 1995. Structural requirements for the anti-inflammatory activity of natural triterpenoids. Planta Medica, 61, 182–185. [CrossRef] [PubMed] [Google Scholar]
  4. Carpenter RC, Sotheeswaran S, Sultanbawa MUS, Ternai B. 1980. 13C NMR studies of some lupane and taraxerane triterpenes. Organic Magnetic Resonance, 14, 462–465. [CrossRef] [Google Scholar]
  5. Cháirez-Ramírez M, Moreno-Jiménez M, González-Laredo R, Gallegos-Infante J, Rocha-Guzmán N. 2016. Lupane-type triterpenes and their anti-cancer activities against most common malignant tumors: a review. EXCLI Journal, 15, Doc758. ISSN 1611–2156. [Google Scholar]
  6. da Cunha EFF, Ramalho TC, Mancini DT, Fonseca EMB, Oliveira AA. 2010. New approaches to the development of anti-protozoan drug candidates: a review of patents. Journal of the Brazilian Chemical Society, 21, 1787–1806. [CrossRef] [Google Scholar]
  7. Daina A, Zoete V. 2016. A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem, 11, 1117–1121. [CrossRef] [PubMed] [Google Scholar]
  8. Darme P, Dauchez M, Renard A, Voutquenne-Nazabadioko L, Aubert D, Escotte-Binet S, Renault J-H, Villena I, Steffenel L-A, Baud S. 2021. AMIDE v2: high-throughput screening based on AutoDock-GPU and improved workflow leading to better performance and reliability. International Journal of Molecular Sciences, 22, 7489. [CrossRef] [PubMed] [Google Scholar]
  9. Darme P, Spalenka J, Hubert J, Escotte-binet S, Debelle L, Villena I, Sayagh C, Borie N, Martinez A, Bertaux B, Voutquenne-nazabadioko L, Renault J-H, Aubert D. 2021. Investigation of antiparasitic activity of ten European tree bark extracts on Toxoplasma gondii and bioguided identification of triterpenes in Alnus glutinosa barks. Antimicrobial Agents and Chemotherapy, 66, e01098-21. https://doi.org/10.1128/AAC.01098-21. [Google Scholar]
  10. De Pablos LM, González G, Rodrigues R, García Granados A, Parra A, Osuna A. 2010. Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii. Journal of Natural Products, 73, 831–834. [CrossRef] [PubMed] [Google Scholar]
  11. Dias R, Azevedo W de Jr. 2008. Molecular docking algorithms. Current Drug Targets, 9, 1040–1047. [CrossRef] [PubMed] [Google Scholar]
  12. Doliwa C, Escotte-Binet S, Aubert D, Velard F, Schmid A, Geers R, Villena I. 2013. Induction of sulfadiazine resistance in vitro in Toxoplasma gondii. Experimental Parasitology, 133, 131–136. [CrossRef] [PubMed] [Google Scholar]
  13. Domínguez-Carmona DB, Escalante-Erosa F, García-Sosa K, Ruiz-Pinell G, Gutierrez-Yapu D, Chan-Bacab MJ, Giménez-Turba A, Peña-Rodríguez LM. 2010. Antiprotozoal activity of betulinic acid derivatives. Phytomedicine, 17, 379–382. [CrossRef] [PubMed] [Google Scholar]
  14. Endo M, Shigetomi K, Mitsuhashi S, Igarashi M, Ubukata M. 2019. Isolation, structure determination and structure–activity relationship of anti-toxoplasma triterpenoids from Quercus crispula Blume outer bark. Journal of Wood Science, 65, 1–11. [CrossRef] [Google Scholar]
  15. Felföldi-Gáva A, Szarka S, Simándi B, Blazics B, Simon B, Kéry Á. 2012. Supercritical fluid extraction of Alnus glutinosa (L.) Gaertn. Journal of Supercritical Fluids, 61, 55–61. [CrossRef] [Google Scholar]
  16. Gachet MS, Kunert O, Kaiser M, Brun R, Zehl M, Keller W, Muñoz RA, Bauer R, Schuehly W. 2011. Antiparasitic compounds from Cupania cinerea with activities against Plasmodium falciparum and Trypanosoma brucei rhodesiense. Journal of Natural Products, 74, 559–566. [CrossRef] [PubMed] [Google Scholar]
  17. Gong Y, Raj KM, Luscombe CA, Gadawski I, Tam T, Chu J, Gibson D, Carlson R, Sacks SL. 2004. The synergistic effects of betulin with acyclovir against herpes simplex viruses. Antiviral Research, 64, 127–130. [CrossRef] [PubMed] [Google Scholar]
  18. Hubert J, Angelis A, Aligiannis N, Rosalia M, Abedini A, Bakiri A, Reynaud R, Nuzillard J-M, Gangloff S, Skaltsounis A-L, Renault J-H. 2016. In vitro dermo-cosmetic evaluation of bark extracts from common temperate trees. Planta Medica, 82, 1351–1358. [CrossRef] [PubMed] [Google Scholar]
  19. Isah MB, Ibrahim MA, Mohammed A, Aliyu AB, Masola B, Coetzer THT. 2016. A systematic review of pentacyclic triterpenes and their derivatives as chemotherapeutic agents against tropical parasitic diseases. Parasitology, 143, 1219–1231. [CrossRef] [PubMed] [Google Scholar]
  20. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23, 3–25. [CrossRef] [Google Scholar]
  21. Loggia R, Tubaro A, Sosa S, Becker H, St Saar, Isaac O. 1994. The role of triterpenoids in the topical anti-inflammatory activity of Calendula officinalis flowers. Planta Medica, 60, 516–520. [CrossRef] [PubMed] [Google Scholar]
  22. Long S, Wang Q, Sibley LD. 2016. Analysis of noncanonical calcium-dependent protein kinases in Toxoplasma gondii by targeted gene deletion using CRISPR/Cas9. Infection and Immunity, 84, 1262–1273. [CrossRef] [PubMed] [Google Scholar]
  23. Luan T, Jin C, Jin C-M, Gong G-H, Quan Z-S. 2019. Synthesis and biological evaluation of ursolic acid derivatives bearing triazole moieties as potential anti-Toxoplasma gondii agents. Journal of Enzyme Inhibition and Medicinal Chemistry, 34, 761–772. [CrossRef] [PubMed] [Google Scholar]
  24. Luft BJ, Remington JS. 1992. Toxoplasmic encephalitis in AIDS. Clinical Infectious Diseases, 15, 211–222. [CrossRef] [PubMed] [Google Scholar]
  25. Mahato SB, Kundu AP. 1994. 13C NMR Spectra of pentacyclic triterpenoids – a compilation and some salient features. Phytochemistry, 37, 1517–1575. [CrossRef] [Google Scholar]
  26. Mao D-B, Feng Y-Q, Bai Y-H, Xu C-P. 2012. Novel biotransformation of betulin to produce betulone by Rhodotorula mucilaginosa. Journal of the Taiwan Institute of Chemical Engineers, 43, 825–829. [CrossRef] [Google Scholar]
  27. Mazumdar J, Wilson EH, Masek K, Hunter CA, Striepen B. 2006. Apicoplast fatty acid synthesis is essential for organelle biogenesis and parasite survival in Toxoplasma gondii. Proceedings of the National Academy of Sciences, 103, 13192–13197. [CrossRef] [PubMed] [Google Scholar]
  28. McLeod R, Muench SP, Rafferty JB, Kyle DE, Mui EJ, Kirisits MJ, Mack DG, Roberts CW, Samuel BU, Lyons RE, Dorris M, Milhous WK, Rice DW. 2001. Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I. International Journal for Parasitology, 31, 109–113. [CrossRef] [PubMed] [Google Scholar]
  29. Montazeri M, Mehrzadi S, Sharif M, Sarvi S, Tanzifi A, Aghayan SA, Daryani A. 2018. Drug resistance in Toxoplasma gondii. Frontiers in Microbiology, 9, 2587. [CrossRef] [PubMed] [Google Scholar]
  30. Montoya J, Liesenfeld O. 2004. Toxoplasmosis. The Lancet, 363, 1965–1976. [CrossRef] [Google Scholar]
  31. Kolobova EN, Pakrieva EG, Carabineiro SAC, Bogdanchikova N, Kharlanov AN, Kazantsev SO, Hemming J, Mäki-Arvela P, Pestryakov AN, Murzin DY. 2019. Oxidation of a wood extractive betulin to biologically active oxo-derivatives using supported gold catalysts. Green Chemistry, 21, 3370–3382. [CrossRef] [Google Scholar]
  32. Prachayasittikul S, Suphapong S, Worachartcheewan A, Lawung R, Ruchirawat S, Prachayasittikul V. 2009. Bioactive metabolites from Spilanthes acmella Murr. Molecules, 14, 850–867. [CrossRef] [PubMed] [Google Scholar]
  33. Qiu W, Wernimont A, Tang K, Taylor S, Lunin V, Schapira M, Fentress S, Hui R, Sibley LD. 2009. Novel structural and regulatory features of rhoptry secretory kinases in Toxoplasma gondii. EMBO Journal, 28, 969–979. [CrossRef] [PubMed] [Google Scholar]
  34. Räsänen R-M, Hieta J-P, Immanen J, Nieminen K, Haavikko R, Yli-Kauhaluoma J, Kauppila TJ. 2019. Chemical profiles of birch and alder bark by ambient mass spectrometry. Analytical and Bioanalytical Chemistry, 411, 7573–7583. [CrossRef] [PubMed] [Google Scholar]
  35. Reynolds MG, Oh J, Roos DS. 2001. In vitro generation of novel pyrimethamine resistance mutations in the Toxoplasma gondii dihydrofolate reductase. Antimicrobial Agents and Chemotherapy, 45, 1271–1277. [CrossRef] [PubMed] [Google Scholar]
  36. de Sá MS, Costa JFO, Krettli AU, Zalis MG, de Azevedo Maia GL, Sette IMF, de Amorim Câmara C, Filho JMB, Giulietti-Harley AM, Ribeiro dos Santos R, Soares MBP. 2009. Antimalarial activity of betulinic acid and derivatives in vitro against Plasmodium falciparum and in vivo in P. berghei-infected mice. Parasitology Research, 105, 275–279. [CrossRef] [PubMed] [Google Scholar]
  37. Salomane N, Pooe OJ, Simelane MBC. 2021. Iso-mukaadial acetate and ursolic acid acetate inhibit the chaperone activity of Plasmodium falciparum heat shock protein 70–1. Cell Stress and Chaperones, 26, 685–693. [CrossRef] [PubMed] [Google Scholar]
  38. Seeliger D, de Groot BL. 2010. Ligand docking and binding site analysis with PyMOL and Autodock/Vina. Journal of Computer-Aided Molecular Design, 24, 417–422. [CrossRef] [PubMed] [Google Scholar]
  39. Sholichin M, Yamasaki K, Kasai R, Tanaka O. 1980. 13C nuclear magnetic resonance of lupane-type triterpenes, lupeol, betulin and betulinic acid. Chemical and Pharmaceutical Bulletin, 28, 1006–1008. [CrossRef] [Google Scholar]
  40. Spalenka J, Escotte-Binet S, Bakiri A, Hubert J, Renault J-H, Velard F, Duchateau S, Aubert D, Huguenin A, Villena I. 2018. Discovery of new inhibitors of Toxoplasma gondii via the pathogen box. Antimicrobial Agents and Chemotherapy, 62, e01640-17. [CrossRef] [PubMed] [Google Scholar]
  41. Stec J, Fomovska A, Afanador GA, Muench SP, Zhou Y, Lai B-S, El Bissati K, Hickman MR, Lee PJ, Leed SE, Auschwitz JM, Sommervile C, Woods S, Roberts CW, Rice D, Prigge ST, McLeod R, Kozikowski AP. 2013. Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii. ChemMedChem, 8, 1138–1160. [CrossRef] [PubMed] [Google Scholar]
  42. Sun H, Fang W-S, Wang W-Z, Hu C. 2006. Structure-activity relationships of oleanane- and ursane- type triterpenoids. Botanical Studies, 47, 31. [Google Scholar]
  43. Vasseur R, Baud S, Steffenel LA, Vigouroux X, Martiny L, Krajecki M, Dauchez M, Team S, Ea Cr. 2014. AMIDE – Automatic Molecular Inverse Docking Engine for large-scale protein targets identification. International Journal on Advances in Life Sciences, 6, 325–337. [Google Scholar]
  44. Vasseur R, Baud S, Steffenel LA, Vigouroux X, Martiny L, Krajecki M, Dauchez M. 2015. Inverse docking method for new proteins targets identification: a parallel approach. Parallel Computing, 42, 48–59. [CrossRef] [Google Scholar]
  45. Wernimont AK, Artz JD, Finerty P, Lin Y-H, Amani M, Allali-Hassani A, Senisterra G, Vedadi M, Tempel W, Mackenzie F, Chau I, Lourido S, Sibley LD, Hui R. 2010. Structures of apicomplexan calcium-dependent protein kinases reveal mechanism of activation by calcium. Nature Structural & Molecular Biology, 17, 596–601. [CrossRef] [PubMed] [Google Scholar]
  46. Zhang L-H, Jin L-L, Liu F, Jin C, Jin C-M, Wei Z-Y. 2020. Evaluation of ursolic acid derivatives with potential anti-Toxoplasma gondii activity. Experimental Parasitology, 216, 107935. [CrossRef] [PubMed] [Google Scholar]
  47. Ziegler HL, Franzyk H, Sairafianpour M, Tabatabai M, Tehrani MD, Bagherzadeh K, Hägerstrand H, Stærk D, Jaroszewski JW. 2004. Erythrocyte membrane modifying agents and the inhibition of Plasmodium falciparum growth. Bioorganic & Medicinal Chemistry, 12, 119–127. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.